Tobacco Induced Diseases, 15, 15
Mechanisms of Action and Cellular Pathways MDPI - Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity: Highlights cytoprotection, neurotransmitter interactions, and VEGF activation
In comparison, a multicenter clinical trial on IGB use reported a total body weight loss of 8.5% at 3 months, 11.8% at 6 months, and 13.3% at 12 months, while semaglutide studies have shown approximately 10.9% weight loss at 6 months and 13.9% at 12 months [12, 13]
If your blood sugar levels have been out of control and youve recently experienced an infection, its possible that the swelling in your lymph nodes is related
Also, taking the medication with food might reduce gastrointestinal side effects